Artículos de revistas sobre el tema "GBM Patients"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "GBM Patients".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Connelly, Jennifer, Kathleen Schmainda, Mona Al-Gizawiy, Fernando Santos-Pinhero y Christopher Chitambar. "TIPS-03 A PHASE 1 STUDY OF GALLIUM MALTOLATE (GAM) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)". Neuro-Oncology Advances 5, Supplement_3 (1 de agosto de 2023): iii34. http://dx.doi.org/10.1093/noajnl/vdad070.134.
Texto completoWu, Mengwan, Ying Shi, Luyi Zhu, Luoyi Chen, Xinchen Zhao y Chuan Xu. "Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword". Life 12, n.º 8 (12 de agosto de 2022): 1225. http://dx.doi.org/10.3390/life12081225.
Texto completoBergallo, Massimiliano, Cristina Costa, Stefano Gambarino, Alessandra Tornicelli, Sara Astegiano, Maria Elena Terlizzi, Paolo Solidoro y Rossana Cavallo. "Human cytomegalovirus glycoprotein B genotyping from bronchoalveolar lavage specimens". Canadian Journal of Microbiology 57, n.º 4 (abril de 2011): 273–77. http://dx.doi.org/10.1139/w11-014.
Texto completoNelson, James S. "Alzheimer Pathology in Elderly Patients With Glioblastoma Multiforme". Archives of Pathology & Laboratory Medicine 126, n.º 12 (1 de diciembre de 2002): 1515–17. http://dx.doi.org/10.5858/2002-126-1515-apiepw.
Texto completoBotturi, M., L. Fariselli, I. Milanesi, D. Asnaghi, S. Bracelli, G. Broggi y D. Zanni. "GBM: A review of 118 patients". European Journal of Cancer 29 (enero de 1993): S193. http://dx.doi.org/10.1016/0959-8049(93)91700-u.
Texto completoNakamura, Masaya, Osahiko Tsuji, Kanehiro Fujiyoshi, Kota Watanabe, Takashi Tsuji, Ken Ishii, Morio Matsumoto, Yoshiaki Toyama y Kazuhiro Chiba. "Cordotomy for patients with thoracic malignant astrocytoma". Journal of Neurosurgery: Spine 13, n.º 4 (octubre de 2010): 418–23. http://dx.doi.org/10.3171/2010.4.spine09901.
Texto completoLarionova, T. D., T. F. Kovalenko, M. I. Shakhparonov y M. S. Pavlyukov. "The Prognostic Significance of Spliceosomal Proteins for Patients with Glioblastoma". Doklady Biochemistry and Biophysics 503, n.º 1 (abril de 2022): 71–75. http://dx.doi.org/10.1134/s1607672922020090.
Texto completoTakeuchi, Yasuo, Emiko Takeuchi y Kouju Kamata. "A Possible Clue for the Production of Anti-Glomerular Basement Membrane Antibody Associated with Ureteral Obstruction and Hydronephrosis". Case Reports in Nephrology and Dialysis 5, n.º 1 (31 de marzo de 2015): 87–95. http://dx.doi.org/10.1159/000381396.
Texto completoChabot, Peter, Dominique Fontaine, Carmen del Genio, Yujia Shentu y Arti Gaur. "BIOM-14. SYSTEMIC BIOMARKERS OF TUMOR BURDEN IN GLIOBLASTOMA PATIENTS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii7. http://dx.doi.org/10.1093/neuonc/noac209.024.
Texto completoBacha, Jeffrey A., Anne Steino, Richard Stephen Schwartz, John Langlands, Sarath Kanekal, Lorena Lopez, Barbara Jane O'Brien, Zhongping Chen, Marta Penas-Prado y Dennis Brown. "Clinical trials of VAL-083 in patients with chemo-resistant glioblastoma." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): TPS2082. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps2082.
Texto completoHorta, Erika, Tobias Walbert y James Snyder. "EPID-11. OCCURRENCE OF SYSTEMIC CANCER IN PATIENTS WITH GLIOBLASTOMA: POPULATION CHARACTERIZATION AND COMPLICATIONS". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi76. http://dx.doi.org/10.1093/neuonc/noz175.311.
Texto completoLynch, David, Branka Powter, Joseph William Po, Adam Cooper, Celine Garrett, Eng-Siew Koh, Mark Sheridan et al. "Isolation of Circulating Tumor Cells from Glioblastoma Patients by Direct Immunomagnetic Targeting". Applied Sciences 10, n.º 9 (11 de mayo de 2020): 3338. http://dx.doi.org/10.3390/app10093338.
Texto completoShi, Zhong-Fang, Guan-Zhang Li, You Zhai, Chang-Qing Pan, Di Wang, Ming-Chen Yu, Chi Liu, Wei Zhang y Xiao-Guang Yu. "EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis". Genes 14, n.º 3 (4 de marzo de 2023): 651. http://dx.doi.org/10.3390/genes14030651.
Texto completoMunoz, Yamhilette Licon, Rachel B. Sidebottom, Frank J. Martinez, Samantha Varela, Christian A. Bowers y Sara G. M. Piccirillo. "Abstract 5802: The impact of tumor-treating fields on cancer stem-like cells isolated from the sub-ventricular zone of glioblastoma patients". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5802. http://dx.doi.org/10.1158/1538-7445.am2023-5802.
Texto completoDamestani, Yasaman, Minesh P. Mehta, Howard Colman, Kevin A. Camphausen, Michael Weller, Evanthia Galanis, Martin J. Van Den Bent et al. "Digital measurement of functional status of patients with glioblastoma." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 2016. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.2016.
Texto completoAlijani, Babak, Hamid Saeidi Saedi, Hadi Hajizadeh Fallah, Ehsan Kazemnejad Leili, Adel Kiumarsi y Sasan Andalib. "Evaluation of effect of epidermal growth factor receptor and vascular endothelial growth factor overexpression in survival of patients with glioblastoma multiforme". Romanian Journal of Neurology 20, n.º 1 (31 de marzo de 2021): 66–71. http://dx.doi.org/10.37897/rjn.2021.1.9.
Texto completoGmurczyk, Aleksandra, Shubhada N. Ahya, Robert Goldschmidt, George Kim, L. Tammy Ho y Kevin Nash. "A Case of Simultaneous, Biopsy-Proven, Classic, ANCA-Positive Wegener's Granulomatosis and Anti-GBM Disease, but without Detectible Circulating Anti-GBM Antibodies". Scientific World JOURNAL 10 (2010): 1078–83. http://dx.doi.org/10.1100/tsw.2010.107.
Texto completoSloan, Anthony, Theresa Elder, Ansh Desai, Anna Wu, Serah Choi y Andrew Sloan. "NCMP-06. VENOUS THROMBOEMBOLISM INCIDENCE AND THE IMPACT OF PRE-DISEASED ANTICOAGULATION THERAPY IN GLIOBLASTOMA PATIENTS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii192. http://dx.doi.org/10.1093/neuonc/noac209.734.
Texto completoTroike, Katie M., Arlet M. Acanda de la Rocha, Tyler J. Alban, Matthew M. Grabowski, Balint Otvos, Gino Cioffi, Kristin A. Waite et al. "The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients". Cancers 13, n.º 18 (8 de septiembre de 2021): 4525. http://dx.doi.org/10.3390/cancers13184525.
Texto completoGiamas, Georgios, Chiara Cilibrasi, Thomas Simon, Nicolas Stewart, Giles Critchley y Murat Eravci. "BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii5. http://dx.doi.org/10.1093/neuonc/noac209.016.
Texto completoCurtin, Lee, Paula Whitmire, Cassandra Rickertsen, Peter D. Canoll, Maciej Mrugala, Kristin Swanson y Leland Hu. "RARE-09. CYSTIC GLIOBLASTOMA PRESENTATION AS A BENEFICIAL PROGNOSTIC INDICATOR FOR OVERALL SURVIVAL". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi223. http://dx.doi.org/10.1093/neuonc/noz175.932.
Texto completoGareev, I. F., O. A. Beylerli, Sh Zhao, G. Yang, J. Sun, A. T. Beilerli y Sh M. Safin. "Extraction of Exosomes from Glioblastoma Multiforme Patients’ Blood Plasma". Creative surgery and oncology 9, n.º 3 (20 de noviembre de 2019): 234–38. http://dx.doi.org/10.24060/2076-3093-2019-9-3-234-238.
Texto completoWu, Zhe Bao, Chao Qiu, An Li Zhang, Lin Cai, Shao Jian Lin, Yu Yao, Qi Sheng Tang et al. "Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma". Journal of Immunology Research 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/131494.
Texto completoSaadeh, Fadi S., Rami Z. Morsi, Abdallah El-Kurdi, Georges Nemer, Rami Mahfouz, Maya Charafeddine, Jessica Khoury, Marwan W. Najjar, Pierre Khoueiry y Hazem I. Assi. "Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population". PLOS ONE 15, n.º 11 (25 de noviembre de 2020): e0242793. http://dx.doi.org/10.1371/journal.pone.0242793.
Texto completoVauleon, Elodie, Tony Avril, Brigitte Collet, Jean Mosser y Véronique Quillien. "Overview of Cellular Immunotherapy for Patients with Glioblastoma". Clinical and Developmental Immunology 2010 (2010): 1–18. http://dx.doi.org/10.1155/2010/689171.
Texto completoShah, Farah y Zhi Sheng. "Using PIK3CB and connexin-43 inhibition to sensitize pediatric glioblastoma cells to temozolomide." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): e13572-e13572. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13572.
Texto completoMontemurro, Nicola, Paolo Perrini y Biagio Rapone. "Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature". International Journal of Environmental Research and Public Health 17, n.º 22 (17 de noviembre de 2020): 8501. http://dx.doi.org/10.3390/ijerph17228501.
Texto completoRichard, Seidu A. "Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma". Disease Markers 2020 (4 de noviembre de 2020): 1–13. http://dx.doi.org/10.1155/2020/8844313.
Texto completoZhou, Chengmao, Ying Wang, Mu-Huo Ji, Jianhua Tong, Jian-Jun Yang y Hongping Xia. "Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning". Cancer Control 27, n.º 1 (1 de enero de 2020): 107327482096890. http://dx.doi.org/10.1177/1073274820968900.
Texto completoLi, Zhiyong, Yinghui Jin, Qingping Zou, Xiaofeng Shi, Kaishu Li, Qun He, Zhiying Lin et al. "Integrated genomic and transcriptomic analysis identified KRT18 mutation and MTAP loss as key genetic alterations related to the prognosis of astrocytoma and glioblastoma." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): e14039-e14039. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14039.
Texto completoCilibrasi, Chiara, Thomas Simon, Marian Vintu, Christos Tolias, Mark Samuels, Nektarios Mazarakis, Murat Eravci, Nicholas Stewart, Giles Critchley y Giorgios Giamas. "Identification of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients". Neuro-Oncology 24, Supplement_4 (1 de octubre de 2022): iv6—iv7. http://dx.doi.org/10.1093/neuonc/noac200.027.
Texto completoSantoni, Giorgio, Federica Maggi, Consuelo Amantini, Antonietta Arcella, Oliviero Marinelli, Massimo Nabissi, Matteo Santoni y Maria Beatrice Morelli. "Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients". International Journal of Molecular Sciences 23, n.º 14 (13 de julio de 2022): 7741. http://dx.doi.org/10.3390/ijms23147741.
Texto completoWelling, Leonardo, José Carlos Lynch, Celestino Pereira, Ricardo Andrade, Fabiana Polycarpo Hidalgo, Alessandra G. L. Pereira y Claúdia Escoteguy. "Prognostic factors in glioblastoma multiforme". Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 29, n.º 04 (diciembre de 2010): 121–25. http://dx.doi.org/10.1055/s-0038-1625613.
Texto completoXia, Xiangping, Fang Cao, Xiaolu Yuan, Qiang Zhang, Wei Chen, Yunhu Yu, Hua Xiao, Chong Han y Shengtao Yao. "Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme". PeerJ 7 (19 de noviembre de 2019): e7974. http://dx.doi.org/10.7717/peerj.7974.
Texto completoDeng, Xinqing, Jian Ren, Zhongsheng Bi y Zhenghao Fu. "Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma". Genetics Research 2022 (26 de diciembre de 2022): 1–10. http://dx.doi.org/10.1155/2022/5435523.
Texto completoHuang, Bin, Ju Yang, Kongcheng Wang, Weitao Chen, Hongbin Ni y Jing Yan. "NF1 may serve as a novel genetic biomarker of response to treatment and prognosis in glioblastoma (GBM)." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e14539-e14539. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14539.
Texto completoBushara, Omar, Alexander Guzner, Kirsten Burdett, Patrick Murday, Matias Pollevick, Denise Scholtens y Priya Kumthekar. "IMMU-44. PRE-DIAGNOSTIC EOSINOPHIL LEVEL AND GLIOBLASTOMA DEVELOPMENT IN PATIENTS WITH AND WITHOUT ATOPIC DISEASE". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii114. http://dx.doi.org/10.1093/neuonc/noaa215.474.
Texto completoSapirstein, E., Y. Laviv, A. Kanner, S. Berkowitch, S. Fichman, A. Benouaich -Amiel, S. Yust-Katz y T. Siegal. "P12.01.B Systemic metabolic features associated with significant insulin resistance in diabetes mellitus type 2 patients are related to the presence of gemistocytes in glioblastoma". Neuro-Oncology 24, Supplement_2 (1 de septiembre de 2022): ii76—ii77. http://dx.doi.org/10.1093/neuonc/noac174.266.
Texto completoPająk, Beata. "Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy". Biomedicines 10, n.º 5 (26 de abril de 2022): 1001. http://dx.doi.org/10.3390/biomedicines10051001.
Texto completoPająk, Beata. "Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy". Biomedicines 10, n.º 5 (26 de abril de 2022): 1001. http://dx.doi.org/10.3390/biomedicines10051001.
Texto completoLiang, Dandan, Shaoshan Liang, Feng Xu, Mingchao Zhang, Xiaomei Li, Yiyao Tu, Zhihong Liu y Caihong Zeng. "Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease". Journal of Clinical Pathology 72, n.º 1 (12 de octubre de 2018): 31–37. http://dx.doi.org/10.1136/jclinpath-2018-205278.
Texto completoChahal, Manik, Brian Thiessen y Caroline Mariano. "Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management". Current Oncology 29, n.º 1 (14 de enero de 2022): 360–76. http://dx.doi.org/10.3390/curroncol29010032.
Texto completoPellerino, Alessia, Francesco Bruno, Edoardo Pronello, Francesca Mo, Federica Franchino, Roberta Rudà y Riccardo Soffietti. "NCOG-19. PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE INSTITUTIONAL SERIES OF 160 PATIENTS". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi156. http://dx.doi.org/10.1093/neuonc/noab196.610.
Texto completoLi, Qiao, Weijie Sun, Yi Lu, Didi Guo, Tiantian Han, Guanghua Lu, Xiaomin Li, Ran Ding y Fanfeng Bu. "The analysis of EGFR variants in Chinese adult glioblastoma patients." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): e14020-e14020. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14020.
Texto completoFrandsen, Simone, Helle Broholm, Vibeke A. Larsen, Kirsten Grunnet, Søren Møller, Hans Skovgaard Poulsen y Signe Regner Michaelsen. "RARE-21. CLINICAL CHARACTERISTICS OF GLIOSARCOMA AND OUTCOME FROM STANDARDIZED TREATMENT RELATIVE TO CONVENTIONAL GLIOBLASTOMA". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi225—vi226. http://dx.doi.org/10.1093/neuonc/noz175.944.
Texto completoOtvos, Balint, Matthew Grabowski, Tyler Alban, Joshua Golubovsky, Chase Neumann, Anja Rabjlenovic, Defne Bayik et al. "GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi103. http://dx.doi.org/10.1093/neuonc/noz175.428.
Texto completoKim, Jung-Young, Jennifer G. Jackman, Sarah Woodring, Frances McSherry, James E. Herndon, Annick Desjardins, Henry S. Friedman y Katherine B. Peters. "Second primary cancers in long-term survivors of glioblastoma". Neuro-Oncology Practice 6, n.º 5 (4 de febrero de 2019): 386–91. http://dx.doi.org/10.1093/nop/npz001.
Texto completoZhai, Lijie, April Bell, Jun Qian, Erik Ladomersky, Kristen Lauing y Derek Wainwright. "IMMU-22. TARGETING NON-CANONICAL FUNCTION OF IDO1 IN GLIOBLASTOMA IMMUNOTHERAPY". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi123. http://dx.doi.org/10.1093/neuonc/noz175.515.
Texto completoLoussouarn, Delphine, Lisa Oliver, Celine Salaud, Edouard Samarut, Raphaël Bourgade, Christophe Béroud, Emilie Morenton, Dominique Heymann y Francois M. Vallette. "Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study". Cancers 15, n.º 12 (20 de junio de 2023): 3256. http://dx.doi.org/10.3390/cancers15123256.
Texto completoO'Brien, B. J., J. A. Bacha, D. M. Brown, A. Steino, R. Schwartz, S. Kanekal, L. M. Lopez y M. Penas-Prado. "PC3 - 155 Phase II Study of Dianhydrogalactitol in Patients with MGMT-Unmethylated, Bevacizumab-Naïve Recurrent Glioblastoma". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43, S4 (octubre de 2016): S18. http://dx.doi.org/10.1017/cjn.2016.382.
Texto completo